Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
7.69
+0.29 (3.92%)
At close: Jun 26, 2026, 4:00 PM EDT
7.66
-0.03 (-0.39%)
After-hours: Jun 26, 2026, 7:49 PM EDT
Xeris Biopharma Holdings Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Xeris Biopharma Holdings stock have an average target of 12.33, with a low estimate of 9.00 and a high estimate of 18. The average target predicts an increase of 60.34% from the current stock price of 7.69.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for Xeris Biopharma Holdings stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 11, 2026 |
| Barclays | Barclays | Buy Reiterates $9 | Buy | Reiterates | $9 | +17.04% | May 14, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Reiterates $18 | Buy | Reiterates | $18 | +134.07% | May 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $10 | Buy | Reiterates | $10 | +30.04% | May 8, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $10 | Buy | Maintains | $10 | +30.04% | Jan 9, 2026 |
Financial Forecast
Revenue This Year
385.99M
from 291.85M
Increased by 32.26%
Revenue Next Year
472.82M
from 385.99M
Increased by 22.50%
EPS This Year
0.14
EPS Next Year
0.40
from 0.14
Increased by 177.19%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 389.5M | 494.0M | |
| Avg | 386.0M | 472.8M | |
| Low | 383.4M | 451.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 33.5% | 28.0% | |
| Avg | 32.3% | 22.5% | |
| Low | 31.4% | 16.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.19 | 0.60 | |
| Avg | 0.14 | 0.40 | |
| Low | 0.10 | 0.24 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 321.1% | |
| Avg | - | 177.2% | |
| Low | - | 68.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.